Stockreport

A Look At Trevi Therapeutics (TRVI) Valuation After FDA Green Light For Phase 3 Trials [Yahoo! Finance]

Trevi Therapeutics, Inc.  (TRVI) 
PDF Trevi Therapeutics (TRVI) shares are in focus after the company completed its End-of-Phase 2 meeting with the U.S. Food and Drug Administration, clearing the way for tw [Read more]